A double-blind dose-ranging study of risedronate in Japanese patients with osteoporosis (a study by the Risedronate Late Phase II Research Group) (Q44429705)

From Wikidata

Jump to navigation Jump to search

scientific article published on April 10, 2003

Language	Label	Description	Also known as
English	A double-blind dose-ranging study of risedronate in Japanese patients with osteoporosis (a study by the Risedronate Late Phase II Research Group)	scientific article published on April 10, 2003

Statements

scholarly article

1 reference

Europe PubMed Central

2 December 2017

A double-blind dose-ranging study of risedronate in Japanese patients with osteoporosis (a study by the Risedronate Late Phase II Research Group) (English)

1 reference

10.1007/S00198-002-1369-9

https://api.crossref.org/works/10.1007/S00198-002-1369-9

30 December 2023

0 references

author name string

M. Shiraki

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12730746

30 December 2023

M. Fukunaga

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12730746

30 December 2023

K. Kushida

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12730746

30 December 2023

H. Kishimoto

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12730746

30 December 2023

Y. Taketani

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12730746

30 December 2023

H. Minaguchi

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12730746

30 December 2023

T. Inoue

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12730746

30 December 2023

R. Morita

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12730746

30 December 2023

H. Morii

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12730746

30 December 2023

K. Yamamoto

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12730746

30 December 2023

Y. Ohashi

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12730746

30 December 2023

H. Orimo

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12730746

30 December 2023

language of work or name

0 references

publication date

10 April 2003

1 reference

Europe PubMed Central

2 December 2017

full work available at URL

http://link.springer.com/content/pdf/10.1007/s00198-002-1369-9.pdf

Portable Document Format

1 reference

10.1007/S00198-002-1369-9

https://api.crossref.org/works/10.1007/S00198-002-1369-9

30 December 2023

http://link.springer.com/article/10.1007/s00198-002-1369-9/fulltext.html

1 reference

10.1007/S00198-002-1369-9

https://api.crossref.org/works/10.1007/S00198-002-1369-9

30 December 2023

http://link.springer.com/content/pdf/10.1007/s00198-002-1369-9

1 reference

10.1007/S00198-002-1369-9

https://api.crossref.org/works/10.1007/S00198-002-1369-9

30 December 2023

Osteoporosis International

1 reference

Europe PubMed Central

2 December 2017

14

1 reference

Europe PubMed Central

2 December 2017

3

1 reference

Europe PubMed Central

2 December 2017

225-234

1 reference

Europe PubMed Central

2 December 2017

https://scigraph.springernature.com/pub.10.1007/s00198-002-1369-9

0 references

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group

1 reference

https://api.crossref.org/works/10.1007%2FS00198-002-1369-9

21 January 2018

Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group.

1 reference

https://api.crossref.org/works/10.1007%2FS00198-002-1369-9

21 January 2018

Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.

1 reference

https://api.crossref.org/works/10.1007%2FS00198-002-1369-9

21 January 2018

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

1 reference

https://api.crossref.org/works/10.1007%2FS00198-002-1369-9

21 January 2018

Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.

1 reference

https://api.crossref.org/works/10.1007%2FS00198-002-1369-9

21 January 2018

Circulating intact parathyroid hormone measured by a two-site immunochemiluminometric assay

1 reference

https://pubmed.ncbi.nlm.nih.gov/12730746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risedronate reverses bone loss in postmenopausal women with low bone mass: results from a multinational, double-blind, placebo-controlled trial. BMD-MN Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/12730746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative analysis of the pyridinium crosslinks of collagen in urine using ion-paired reversed-phase high-performance liquid chromatography

1 reference

https://pubmed.ncbi.nlm.nih.gov/12730746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose-proportional pharmacokinetics of risedronate on single-dose oral administration to healthy volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/12730746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of a cytosol radioreceptor assay with a radioimmunoassay for 1,25-dihydroxyvitamin D in serum or plasma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12730746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-masked multicenter comparative study between alendronate and alfacalcidol in Japanese patients with osteoporosis. The Alendronate Phase III Osteoporosis Treatment Research Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/12730746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sandwich immunoassay specific for the N-terminal sequence of osteocalcin

1 reference

https://pubmed.ncbi.nlm.nih.gov/12730746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00198-002-1369-9

1 reference

Europe PubMed Central

2 December 2017

1 reference

Europe PubMed Central

2 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44429705&oldid=2041741941"